matriptase inhibitors (Medical Research Council Technology)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namematriptase inhibitors (Medical Research Council Technology)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSuppressor of tumorigenicity 14 protein inhibitors
TargetsSuppressor of tumorigenicity 14 protein
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLifearc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLifearc
Active IndicationsN/A
Inactive IndicationsOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A